Search
Close this search box.
Logo Asphalion

Asphalion is a proud member of the iHivarna consortium

The four-year 6M Euro project, iHivarna consortium, funded by the European Commission, aims to successfully immunize antiretroviral-treated HIV-infected patients.

The four-year 6M Euro project, iHivarna consortium, funded by the European Commission, aims to successfully immunize antiretroviral-treated HIV-infected patients.
December 18, 2013

The iHIVARNA project
(full title: Therapeutic TriMIx / mRNA based Vaccine in Chronic HIV-1 Infected Patients on Antiretroviral Therapy) is funded with approximately 6 million Euro granted by the European Commission in the 7th Framework Programme, coordinated by Dr. Felipe García of IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer) and carried out by 8 leading research
institutions and SMEs.

The iHIVARNA vaccine candidate is the result of a long lasting scientific track record of the Consortium. The candidate is based on an innovative approach that uses naked mRNA, so far has only been recently applied in the cancer research field.The HIV-TriMix-mRNA has two parts: HIV that has been rationally designed by IrsiCaixa based on data from large international cohorts; and TriMix designed by Vrije Universiteit Brussel to activate and target dendritic cells to improve the HIV antigen presentation. The combination of mRNA, rationally designed HIV antigen and TriMix is a very innovative approach for a therapeutic vaccine and is expected to improve the results of other more traditional strategies already tested.
Asphalion will be in charge of all the Regulatory Affairs and procedures with medical authorities of the consortium.
The full list of participating institutions is:
  • Consorci Institut d’Investigacions Biomèdiques August Pi
    i Sunyer (IDIBAPS)
  • Instituut voor Tropische Geneeskunde (ITM)
  • Vrije Universiteit Brussel (VUB)
  • eTheRNA BVBA (eTheRNA)
  • Erasmus Universitair Medisch Centrum Rotterdam (EMC)
  • Institut de Recerca de la Sida – Caixa (IRSICAIXA)
  • Synapse Research Management Partners S.L. (SYNAPSE)
  • Asphalion (ASPHALION)

 

For more information, please read the iHivarna website or contact:

Ms. Mireia Manent
Project Manager, SYNAPSE
mmanent@synapse-managers.com
T +34 933 006 061

Ms. Montse Pérez
Marketing Department, ASPHALION
mperez@asphalion.com
T +34 93 238 59 45

 

iHIVARNA: The research leading to this results has received funding from the European Comunity’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 602570.

Search News & Events

  • Filter by category

Share

Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting